Stevanato Group S.p.A. (NYSE:STVN) Receives Consensus Rating of “Moderate Buy” from Analysts

Stevanato Group S.p.A. (NYSE:STVN) has been given a consensus rating of “Moderate Buy” by the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company.

Several equities analysts have weighed in on the company. BNP Paribas assumed coverage on Stevanato Group in a research report on Monday, April 22nd. They issued an “outperform” rating for the company. Morgan Stanley lowered their price objective on Stevanato Group from $26.00 to $22.00 and set an “equal weight” rating for the company in a research report on Monday, July 15th.

Stevanato Group Price Performance

NYSE STVN opened at €19.21 ($20.88) on Friday. The company has a quick ratio of 1.35, a current ratio of 1.92 and a debt-to-equity ratio of 0.21. The stock has a 50-day moving average of €19.28 and a two-hundred day moving average of €25.58. Stevanato Group has a 1-year low of €16.56 ($18.00) and a 1-year high of €36.30 ($39.46).

Stevanato Group (NYSE:STVN) last released its earnings results on Thursday, May 9th. The company reported €0.09 ($0.10) earnings per share for the quarter, missing the consensus estimate of €0.12 ($0.13) by (€0.03) (($0.03)). The firm had revenue of €256.24 million during the quarter, compared to analyst estimates of €261.28 million. Stevanato Group had a net margin of 12.57% and a return on equity of 12.61%. On average, sell-side analysts anticipate that Stevanato Group will post 0.53 earnings per share for the current fiscal year.

Stevanato Group Announces Dividend

The business also recently disclosed an annual dividend, which was paid on Monday, July 15th. Stockholders of record on Tuesday, June 4th were given a dividend of $0.053 per share. This represents a dividend yield of 0.29%. The ex-dividend date of this dividend was Tuesday, June 4th. Stevanato Group’s dividend payout ratio is presently 10.91%.

Hedge Funds Weigh In On Stevanato Group

A number of institutional investors and hedge funds have recently made changes to their positions in STVN. SRS Capital Advisors Inc. lifted its stake in Stevanato Group by 327.1% during the fourth quarter. SRS Capital Advisors Inc. now owns 1,593 shares of the company’s stock worth $43,000 after purchasing an additional 1,220 shares during the last quarter. Hilltop National Bank lifted its stake in Stevanato Group by 34.3% during the second quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock worth $81,000 after purchasing an additional 1,122 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in Stevanato Group by 54.2% during the fourth quarter. PNC Financial Services Group Inc. now owns 3,089 shares of the company’s stock worth $84,000 after purchasing an additional 1,086 shares during the last quarter. Fifth Third Bancorp lifted its stake in Stevanato Group by 62.1% during the fourth quarter. Fifth Third Bancorp now owns 4,009 shares of the company’s stock worth $109,000 after purchasing an additional 1,536 shares during the last quarter. Finally, First Horizon Advisors Inc. lifted its stake in Stevanato Group by 14.1% during the fourth quarter. First Horizon Advisors Inc. now owns 5,311 shares of the company’s stock worth $145,000 after purchasing an additional 657 shares during the last quarter.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.